Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A10BA02	METFORMINE ARROW LAB	G	Metformin - 1000mg	1000mg	Tablet, film coated, scored	237,860 L.L
N06DX01	MEMANTINE ARROW LAB	G	Memantine HCl - 10mg	10mg	Tablet, film coated, scored	1,404,315 L.L
L04AA06	MYFORTIC	B	Mycophenolic acid (sodium) - 360mg	360mg	Tablet, gastroresistant	20,324,991 L.L
A02BC05	METAPRO	G	Esomeprazole - 40mg	40mg	Tablet, gastroresistant	639,669 L.L
L04AA06	MYFORTIC	B	Mycophenolic acid (sodium) - 360mg	360mg	Tablet, gastroresistant	L.L
H01BA02	MINIRIN MELT	B	Desmopressin - 120mcg	120mcg	Tablet, Oral lyophilisate	4,970,873 L.L
H01BA02	MINIRIN MELT	B	Desmopressin - 60mcg	60mcg	Tablet, Oral lyophilisate	2,484,765 L.L
A03FA03	MOTIDOL ODT	G	Domperidone - 10mg	10mg	Tablet, orodispersible	259,810 L.L
N05CH01	MELATONINE ARROW LP	G	Melatonin - 2mg	2mg	Tablet, prolonged release	1,716,087 L.L
N05AN01	MANICARB SR-400	G	Lithium carbonate - 400mg	400mg	Tablet, prolonged release	1,431,192 L.L
B03BB01	MED-FOLIC ACID	G	Folic acid - 5mg	5mg	Tablet, scored	355,798 L.L
J01RA	MEDSPIRAGYL	G	Metronidazole - 125mg, Spiramycin - 750,000IU		Tablet, scored	474,824 L.L
N02BE51	MAXIFEN	G	Paracetamol - 325mg, Ibuprofen - 400mg		Tablet, scored	225,254 L.L
M03BC51	MUSCEROL 2	G	Paracetamol - 450mg, Orphenadrine (citrate) - 35mg		Tablet, scored	177,899 L.L
M03BC51	MUSCEROL EXTRA	G	Caffeine - 15mg, Paracetamol - 450mg, Orphenadrine citrate - 35mg		Tablet, scored	267,489 L.L
C01DX12	MOLSIDOMINE BIOGARAN	G	Molsidomine - 2mg	2mg	Tablet, scored	256,674 L.L
C01DX12	MOLSIDOMINE BIOGARAN	G	Molsidomine - 2mg	2mg	Tablet, scored	713,580 L.L
N06AA21	MEFIDIOMIL	B	Maprotiline - 25mg	25mg	Tablet, sugar coated	909,973 L.L
N06AA21	MEFIDIOMIL	B	Maprotiline - 75mg	75mg	Tablet, sugar coated	958,608 L.L
G03AB03	MICROGYNON '30'	B	Ethinylestradiol - 0.03mg, Levonorgestrel - 0.15mg		Tablet, sugar coated	161,261 L.L
N07AA02	MESTINON	B	Pyridostigmine bromide - 60mg	60mg	Tablet, sugar coated	3,090,838 L.L

...